Building a Compliance Training Program
This year Q1’s Life Science Ethics & Compliance Training Conference is taking place in June in Chicago. Join us to hear from industry experts, including Daniel Simon from STERIS Corporation.
read more
Panel Preview: Reaching Success In Partnerships With Translation Providers
Anita Stever, Senior Technical Writer at ACIST Medical Systems and Sara Brouillette, Senior Global Labeling Specialist at bioMérieux share insights on their upcoming panel.
read more
Data Integrity for Automation Engineers
Frederick Johnson of Genentech, Inc. is one of many experts presenting at Q1’s Life Sciences Manufacturing Automation Optimization Conference this April.
read more
Understanding GUDID
Dawn Fowler, Director, UDI/Master Data Management at Masimo shares insight into her presentation at the 9th Annual Medical Device & Diagnostic Labeling Conference.
read more
Mapping KOL Relationships
Q1’s 4th Annual Pharma & Biotech Medical Affairs Pre-Launch Strategies Conference taking place on April 29-30 features a mix of industry perspectives from experts, including Daniel Snyder of Revance Therapeutics, Inc.
read more Data Integrity for Automation Engineers
Frederick Johnson of Genentech, Inc. is one of many experts presenting at Q1’s Life Sciences Manufacturing Automation Optimization Conference this April.
read more
Patient Reported Outcomes’ Influence on Pre-Launch Activities
Q1’s 4th Annual Pharma & Biotech Medical Affairs Pre-Launch Strategies Conference features an array of payer, legal and industry perspectives, including Ann Leon of CSL Behring. Learn about her experience and upcoming session below!
read more Understanding GUDID
Dawn Fowler, Director, UDI/Master Data Management at Masimo shares insight into her presentation at the 9th Annual Medical Device & Diagnostic Labeling Conference.
read more Mapping KOL Relationships
Q1’s 4th Annual Pharma & Biotech Medical Affairs Pre-Launch Strategies Conference taking place on April 29-30 features a mix of industry perspectives from experts, including Daniel Snyder of Revance Therapeutics, Inc.
read more
FDA Regulatory Issues and Solutions
Jeff Gibbs from Hyman, Phelps & McNamara will be participating in the panel “Optimizing Primary Mode of Action Determination & Process to Appeal FDA Decisions” at Q1’s Combination Product Regulation Conference. See what he has to say on FDA regulatory issues below!
read more
Telehealth tactics: A look at Penn Medicine’s three-tiered approach
Penn Medicine uses a unique approach to help their hospital succeed. A part of their approach is using video technology to enhance communication and collaboration. This technology can also be used for learning within OR suites as well as remote patient monitoring. See...
read more
Teva Is Laying Off 14,000 Workers, Suspending Its Dividend
As the year comes to a close, Teva Pharmaceutical announced that they will be downsizing drastically. They will be laying off a quarter of their workforce, suspending its dividend and foregoing annual bonuses to help reduce costs. To read the full article, click here.
read more
Hospitals Merge To Protect Turf As CVS And Optum Move In
CVS Health has confirmed they are buying Aetna, the health insurance company. This has brought up many discussions about other health groups and hospitals merging to keep their footing in the industry. There was over 5,000 independent community hospitals in the...
read more
FDA Issues Draft Guidance on Gluten Labeling for Drugs
The FDA issued a draft guidance that encourages drugmakers to provide more detailed labeling about whether their products are made from ingredients that contain gluten. This comes from many questions and concerns about oral drugs containing wheat gluten or wheat...
read moreCONTACT US
Q1 Productions
1 W Monroe St 4th Floor
Chicago, IL 60603
T: 312.822.8100
marketing@q1productions.com
